Diamyd’s new share issue substantially oversubscribed
Diamyd Medical reports today that the Company’s rights issue of just under 220 MSEK has been substantially oversubscribed. Subscriptions equal to a total sum of 384 MSEK have been received.3 109 514 shares have been subscribed and paid for with the support of subscription rights, totalling a payment of 217 665 980 SEK. This represents 99.3 percent of the total subscription rights. Those who exercised their subscription rights have received interim shares (BTA), traded on the Nasdaq OMX in Stockholm (Small Cap list) with ticker DIAM BTA 1B, until registration is processed at Bolagsverket.